Banner
References
Mieloma multiplo: complicanze riabilitative
published in March - April 2009 - in Il Fisioterapista - issue n.2

There are no translations available.

Bibliografia

  • Badros A, Goloubeva O, Dalas JS et al. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer, 2007 Sep 1; 110(5): 1042-9.

  • Barosi G, Boccadoro M, Cavo M et al. Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). Haematologica. 2004 Jun; 89 ( 6 ): 717-41 .

  • Benson WJ, scarffe JH, Todd ID, Palmer M, Crowther D. Spinal cord compression in myeloma. Br Med J 1979; 1(6177): 1541-4.

  • Brenner B, Carter A, Tatarsky I, Gruszkiewicz J, Peyser E. Incidence, prognostic significance and therapeutic modalities of central nervous system involvement in multiple myeloma. Acta Haematol 1982; 68(2): 77-83.

  • Bunting RW , Shea B . Bone metastasis and rehabilitation. Cancer. 2001Aug 5; 92(4 Suppl): 1020-8.

  • Callander NS , Roodman GD . Myeloma bone disease. Semin Hematol. 2001 Jul; 38(3): 276-85.

  • Camacho J et al. The spectrum of neurological manifestations in myeloma. J Med 1985; 16(5-6): 597-611.

  • Cavaletti G, Nobile-Orazio E. Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Hematologica 2007; 92(10): 1308-10.

  • Chang SA, Lee SS, Ueng SW, Yuan LJ, Shih CH. Surgical treatment for pathological long bone fracture in patient with multiple myeloma: a retrospective analysis of 22 cases. Chang Gung Med J 2001 May; 24(5): 300-6.

  • Cheung G, Chow E, Holden L, Vidmar M, Danjoux C, Yee AJ, Connolly R, Finkelstein J. Percuteneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: a prospective study using quality-of-life assesment. Can Assoc Radiol J 2006 Feb; 57(1): 13-21.

  • Coleman EA , Coon S , Hall-Barrow J et al. Feasibility of exercise during treatment for multiple myeloma. Cancer Nurs 2003 Oct; 26(5): 410-9.

  • Coleman EA , Coon S , Kennedy RL et al. Effect of exercise in combination with epoetin alfa during high-dose chemiotherapy and autologous peripheral blood stem cell transplantation for mulitple myeloma. Oncol Nurs Forum 2008; 35(3): E53-61.

  • Courneya KS , Keats MR , Turner AR . Physical exercise and quality of life in cancer patients following high dose chemotherapy and autologous bone marrow transplantation. Psychooncology. 2000 Mar-Apr; 9(2): 127-36.

  • D’Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M. Guidelines for the use of imaging in the management of myeloma. Br J Haematol 2007; 137(1): 49-63.

  • Dimeo F , Fetscher S , Lange W , Mertelsmann R , Keul J . Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood. 1997 Nov 1; 90(9): 3390-4.

  • Dimeo FC , Tilmann MH , Bertz H , Kanz L , Mertelsmann R , Keul J . Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer. 1997 May 1; 79(9): 1717-22.

  • Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-5.

  • Durie BMG et al. Myeloma managemente guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J (2003)4; 379-98.

  • Durr HR, Kuhne JH, Hagena FW, Moser T, Refior HJ. Surgical treatment for myeloma of the bone. A retrospective analysis of 22 cases. Arch Orthop Trauma Surg. 1997; 116(8): 463-9.

  • Durr HR, Wegener B, Krodel A, Muller PE, Jansson V, Refior HJ. Multiple myeloma: surgery of the spine: retrospective analysis of 27 patients. Spine. 2002 Feb 1; 27(3): 320-4.

  • Hjertner O, Standal T , Børset M , Sundan A , Waage A . Bone disease in multiple myeloma. Med Oncol 2006; 23(4): 431-41.

  • Hussein MA. Multiple myeloma: most common end-organ damage and management. J Netl Compr Canc Netw 2007 Feb; 5(2): 170-8.

  • Isoardo B, Bergui M, Durelli L et al. Thalidomide neurophaty: clinical, electrophysiological and neuroradiological features. Acta Neurol Scand 2004 Mar; 109(3): 188-93.

  • Jones LW , Courneya KS , Vallance JK , Ladha AB , Mant MJ , Belch AR , Stewart DA , Reiman T . Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 2004 Nov; 12(11): 780-8.

  • Laaksonen S, Remes K, Koskela K, Voipio-Pulkki LM Falk B. Thalidomide therapy and polyneuropathy in myeloma patients. Electromyogr Clin Neurophysiol 2005; 45(2): 75-86.

  • Latif T, Hussein MA. Advances in multiple myeloma and spine disease. Clin Lymphoma Myeloma 2005; 6(3): 228-33.

  • McDonald RJ, Trout AT, Gray LA, et al. Vertebroplasty in multiple myeloma: outcomes in large patient series. AJNR Am J Neuroradiol 2008; 29(4): 642-8.

  • McKinley WO , Conti-Wyneken AR , Vokac CW , Cifu DX . Rehabilitative functional outcome of patients with neoplastic spinal cord compressions. Arch Phys Med Rehabil 1996 Sep; 77(9): 892-5.

  • Melton LJ, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res 2005; 20(03): 487-93.

  • MockV, Atkinson A, Barsevick A et al. NCCN practice guidelines for cancer related fatigue. Oncology 2000; 4: 151-61.

  • Nair SP, Pearson SB. Images in clinical medicine. Pathologic fractures and lytic bone lesions in multiple myeloma. N Engl J Med 2004; 351(18): 1874.

  • Palumbo A , Petrucci MT , Lauta VM , Musto P , Caravita T , Barbui AM , Nunzi M , Boccadoro M ; Italian Multiple Myeloma Study Group . Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study. Haematologica 2005 Jun; 90(6): 858-60.

  • Papagelopuolos PJ, Galanis EC, Greipp PR, Sim FH. Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma. Clin Orthop Relat Res 1997 Aug; (341): 192-205.

  • Plasmati R, Pastorelli F, Cavo M et al. Neurophaty in multiple myeloma treated with thalidomide: a propsective study. Neurology. 2007 Aug 7; 69(6): 573-81.

  • Pollard JD, Young GAR. Neurology and the bone marrow. Journal of neurology, Neurosurgery and Psychiatry 1997; 63: 706-18.

  • Silberman J, Lonial S. Review of peripheral neuropathy in plasma cell disorders. Hematol Oncol 2008 Jun; 26(2): 55-65.

  • Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of the multiple myeloma 2005. British Journal of Haematology 2005; 132; 410-51.

  • Spiess JL, Adelstein DJ, Hines JD. Multiple myeloma presenting with spinal cord compression. Oncology 1988; 45(2): 88-92.

  • Takei T, Coles M. Treatment of pathologic fracture and surgical value of prognostic factors in multiple myeloma. Int Surg 1996; 81(4): 403-6.

  • Van Weert E , Hoekstra-Weebers J , Otter R , Postema K , Sanderman R , van der Schans C . Cancer-related fatigue: predictors and effects of rehabilitation. Oncologist 2006 Feb; 11(2): 184-96.

  • Yeh HS, berenson JR. Myeloma bone disease and treatment options. Eur J Cancer 2006; 42(11): 1554-63.


 
There are no translations available.